MedPath
NMPA Approval

Dapagliflozin Tablets

国药准字H20253304

January 24, 2025

Drug Information

达格列净片

片剂

10mg (以C₂₁H₂₅ClO₆计)

化学药品

January 24, 2025

Company Information

Applicant Company

石家庄高新区天山南大街585号日中天科技园1406-16

Manufacturing Company

山东省潍坊市高密市高密高新技术产业开发区高新二路(西)6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达格列净片 - NMPA 批准文号 | MedPath